29 Results

People

  1. Kris
    Kris
  2. Seshan
    Seshan
  3. Miller
    Miller
  4. Azzoli
    Azzoli
  5. Krug
    Krug
  6. Rizvi
    Rizvi
  7. Rusch
    Rusch
  8. Riely
    Riely
  9. Gomez
    Gomez
  10. Pao
    Pao

Groups

  1. Department of Medicine (29)
  2. Epidemiology and Biostatistics (29)
  3. Solid Tumor Oncology Division (29)
  4. Thoracic Oncology (29)
  5. Biostatistics Service (27)
  6. Center for Pancreatic Cancer Research (16)
  7. Survivorship Research (11)
  8. Population Sciences Research Program (10)
  9. Nursing (9)
  10. Surgery (9)
  1. "controlled study"
  2. "Mark Kris"
  3. "Epidemiology and Biostatistics"
Formats
  1. Journal Article (28)
  2. Conference Paper (1)
Groups
  1. Department of Medicine (29)
  2. Epidemiology and Biostatistics (29)
  3. Solid Tumor Oncology Division (29)
  4. Thoracic Oncology (29)
  5. Biostatistics Service (27)
  6. Center for Pancreatic Cancer Research (16)

More Groups

People
  1. Mark Kris (29)
  2. Venkatraman Seshan (14)
  3. Vincent Miller (11)
  4. Christopher Azzoli (9)
  5. Lee Krug (8)
  6. Maureen Zakowski (7)

More People

Years
  1. 2023 (1)
  2. 2022 (1)
  3. 2020 (1)
  4. 2018 (2)
  5. 2012 (2)
  6. 2011 (1)

More Years

Publications
  1. Clinical Cancer Research (5)
  2. Journal of Clinical Oncology (5)
  3. Cancer (4)
  4. Journal of Thoracic Oncology (4)
  5. Annals of Thoracic Surgery (3)
  6. JNCI: Journal of the National Cancer Institute (2)

More Publications

Publishers
  1. American Association for Cancer Research (5)
  2. American Society of Clinical Oncology (5)
  3. Elsevier Inc. (5)
  4. Wiley Blackwell (4)
  5. Elsevier Science, Inc. (3)
  6. Elsevier Ireland Ltd. (2)

More Publishers

Results (29)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Clinicopathologic outcomes of preoperative targeted therapy in patients with clinical stage I to III non–small cell lung cancer
    Conference Paper

    Lengel, H. B.; Zheng, J.; Tan, K. S.; Liu, C. C.; Park, B. J.; Rocco, G.; Adusumilli, P. S.; Molena, D.; Yu, H. A.; Riely, G. J.; more...
    Mosby Elsevier (2023)

    Fulltext@MSK | Save
  • Randomized phase II trial of proton craniospinal irradiation versus photon involved-field radiotherapy for patients with solid tumor leptomeningeal metastasis
    Journal Article

    Yang, J. T.; Wijetunga, N. A.; Pentsova, E.; Wolden, S.; Young, R. J.; Correa, D.; Zhang, Z.; Zheng, J.; Steckler, A.; Bucwinska, W.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Clinical outcomes, local–regional control and the role for metastasis-directed therapies in stage III non-small cell lung cancers treated with chemoradiation and durvalumab
    Journal Article

    Offin, M.; Shaverdian, N.; Rimner, A.; Lobaugh, S.; Shepherd, A. F.; Simone, C. B. 2nd; Gelblum, D. Y.; Wu, A. J.; Lee, N.; Kris, M. G.; more...
    Radiotherapy and Oncology (2020)

    Fulltext@MSK | Save
  • Effects of co-occurring genomic alterations on outcomes in patients with KRAS-mutant non-small cell lung cancer
    Journal Article

    Arbour, K. C.; Jordan, E.; Kim, H. R.; Dienstag, J.; Yu, H. A.; Sanchez-Vega, F.; Lito, P.; Berger, M.; Solit, D. B.; Hellmann, M.; more...
    Clinical Cancer Research (2018)

    Fulltext@MSK | Save
  • Twice weekly pulse and daily continuous-dose erlotinib as initial treatment for patients with epidermal growth factor receptor–mutant lung cancers and brain metastases
    Journal Article

    Arbour, K. C.; Kris, M. G.; Riely, G. J.; Ni, A.; Beal, K.; Daras, M.; Hayes, S. A.; Young, R. J.; Rodriguez, C. R.; Ahn, L.; more...
    Cancer (2018)

    Fulltext@MSK | Save
  • Correlation between tumor measurement on Computed Tomography and resected specimen size in lung adenocarcinomas
    Journal Article

    Lampen Sachar, K.; Zhao, B.; Zheng, J.; Moskowitz, C. S.; Schwartz, L. H.; Zakowski, M. F.; Rizvi, N. A.; Kris, M. G.; Ginsberg, M. S.
    Lung Cancer (2012)

    Fulltext@MSK | Save
  • Immunization with N-propionyl polysialic acid-KLH conjugate in patients with small cell lung cancer is safe and induces IgM antibodies reactive with SCLC cells and bactericidal against group B meningococci
    Journal Article

    Krug, L. M.; Ragupathi, G.; Hood, C.; George, C.; Hong, F.; Shen, R.; Abrey, L.; Jennings, H. J.; Kris, M. G.; Livingston, P. O.
    Cancer Immunology, Immunotherapy (2012)

    Fulltext@MSK | Save
  • Impact on disease-free survival of adjuvant erlotinib or gefitinib in patients with resected lung adenocarcinomas that harbor EGFR mutations
    Journal Article

    Janjigian, Y. Y.; Park, B. J.; Zakowski, M. F.; Ladanyi, M.; Pao, W.; D'Angelo, S. P.; Kris, M. G.; Shen, R.; Zheng, J.; Azzoli, C. G.
    Journal of Thoracic Oncology (2011)

    Fulltext@MSK | Save
  • Analysis of genetic variants in never-smokers with lung cancer facilitated by an internet-based blood collection protocol: A preliminary report
    Journal Article

    Girard, N.; Lou, E.; Azzoli, C. G.; Reddy, R.; Robson, M.; Harlan, M.; Orlow, I.; Yatabe, Y.; Nafa, K.; Ladanyi, M.; more...
    Clinical Cancer Research (2010)

    Fulltext@MSK | Save
  • Randomized phase II study of pulse erlotinib before or after carboplatin and paclitaxel in current or former smokers with advanced non-small-cell lung cancer
    Journal Article

    Riely, G. J.; Rizvi, N. A.; Kris, M. G.; Milton, D. T.; Solit, D. B.; Rosen, N.; Senturk, E.; Azzoli, C. G.; Brahmer, J. R.; Sirotnak, F. M.; more...
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save